CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Adenoma, Islet Cell D007516 7 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Nicosia SV and Tojo R Morphogenetic reaggregation and luteinization of mouse preantral follicle cells. 1979 Am. J. Anat. pmid:532792
Rhoten WB Emiocytosis of B granules from saurian pancreatic islets perifused in vitro. 1973 Am. J. Anat. pmid:4585905
Bondareff W and Tuttle RL Cortical cytoplasm and configurational changes of RGC-6 cells exposed to cytochalasin B. 1975 Am. J. Anat. pmid:1211367
Holtzer H et al. Effects of cytochalasin-B and colcimide on cells in muscle cultures. 1974 Am. J. Anat. pmid:4413125
Berkow RL and Dodson RW Functional analysis of the marginating pool of human polymorphonuclear leukocytes. 1987 Am. J. Hematol. pmid:3026170
Standley PR and Rose KA Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature. 1994 Am. J. Hypertens. pmid:8031552
Wann JG et al. Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling. 2006 Am. J. Kidney Dis. pmid:16731301
Jacobs DB Fat cells: model system to investigate molecular mechanism(s) of sulfonylurea-potentiated glucose transport. 1985 Am. J. Med. pmid:3931463
Sato N et al. Hyposmolarity stimulates myeloperoxidase exocytosis from human polymorphonuclear leukocytes. 1990 Am. J. Med. Sci. pmid:2159710
Mooradian AD and Morin AM Brain uptake of glucose in diabetes mellitus: the role of glucose transporters. 1991 Am. J. Med. Sci. pmid:2000888
Liu S et al. Dynamic modulation of cytoskeleton during in vitro maturation in human oocytes. 2010 Am. J. Obstet. Gynecol. pmid:20579967
Kniss DA et al. Expression of functional insulin-like growth factor-I receptors by human amnion cells. 1993 Am. J. Obstet. Gynecol. pmid:8372873
Russo MA et al. Ultrastruct pathology of phalloidin-intoxicated hepatocytes in the presence and absence of extracellular calcium. 1982 Am. J. Pathol. pmid:6890315
Fantone JC et al. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. 1984 Am. J. Pathol. pmid:6324595
Díaz-Ricart M et al. Inhibition of cytoskeletal assembly by cytochalasin B prevents signaling through tyrosine phosphorylation and secretion triggered by collagen but not by thrombin. 2002 Am. J. Pathol. pmid:11786426
Matsumura N et al. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). 1999 Am. J. Pathol. pmid:10362789
Ward PA et al. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors. 1984 Am. J. Pathol. pmid:6087668
Ohta M et al. Changes in the organization and antigenic determinants of intermediate filaments of rat hepatocytes after infusion of cytochalasin B in vivo. 1988 Am. J. Pathol. pmid:2462355
Escolar G et al. Organization of the actin cytoskeleton of resting and activated platelets in suspension. 1986 Am. J. Pathol. pmid:2870643
Wysolmerski RB and Lagunoff D Inhibition of endothelial cell retraction by ATP depletion. 1988 Am. J. Pathol. pmid:3394800